FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> drug safety | Vytorin | Zocor

FDA: Drug combo spawns muscle injury

Tools

Muscle injury warning, part two: The FDA says mixing Zocor (simvastatin), with the heart rhythm med amiodarone boosts the risk of muscle injury, especially in elderly patients. The same goes for Vytorin, because it contains simvastatin. Amiodarone is marketed by Wyeth under the brand name Cordarone and as Pacerone by Upsher-Smith Laboratories.

The FDA has warned about the risks of combining a statin and amiodarone before. But since that warning, in 2002, the agency has received 52 reports of serious muscle injury to patients on the combo, and almost all of them had to be hospitalized.

As you know, muscle injury is a danger attendant on all statin meds, especially at higher doses. The overall risk is low, but if it happens, it can be serious, even fatal. And this is the second bit of news in less than a week about a statin interacting dangerously with another med; in Ireland, one man recently died while he was taking Lipitor along with an antibiotic, fucidic acid.

- read the Associated Press story
- check out the Wall Street Journal coverage

Related Articles:
Merck slashes Zocor price as patent expires
Ireland probes Lipitor patient's death

Bookmark and Share
Get Your FREE FiercePharma Email Newsletter:
Comments (2) | Post a comment
More stories about Zocor   drug safety   Vytorin  

Comments

Statins and macrolide antibiotics as a class should never be taken together.

When was Amiodarone approvoved for use in the U.S.? ( as Cordarone in pill form)

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.